Red Cell Transfusion in Critical Care Patients Alan Tinmouth, MD MSc University of Ottawa Centre for Transfusion Research, Ottawa Health Research Institute.

Slides:



Advertisements
Similar presentations
Efficacy and Safety of Epoietin Alfa in Critically Ill Patients NEJM 2007, 357: TMR Journal Club October 10, 2007 Katerina Pavenski, MD FRCPC TM.
Advertisements

A Clinical Evaluation of Terumo’s Prescriptive Oxygenation™ Series Capiox® FX15 and FX25 Hollow Fiber oxygenators with Integrated Arterial Filter in the.
The golden hour(s) for severe sepsis and septic shock treatment
Anemia an enigma in chronic kidney disease Mohammad Asgar Khan, MD.
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
A Randomized Trial of Protocol-Based Care for Early Septic Shock Andrea Caballero, MD January 15, 2015 LSU Journal Club The ProCESS Investigators. N Engl.
Physiology of Acute Anemia John R. Feiner, MD Department of Anesthesia and Perioperative Care University of California, San Francisco.
Anemia in the ICU: An Evidence Based Approach Andrew F. Shorr, MD, MPH Walter Reed Army Medical Center.
Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.
Pablo M. Bedano M.D. Community Regional Cancer Care.
Ammar Alsughayir TM Fellow The University of Ottawa April 9 th 2008.
Epoetin Alfa & Increased Mortality Maria Shin, Pharm.D. Pharmacy Resident (PGY-1) Kingsbrook Jewish Medical Center Clinical Instructor of Pharmacy Practice.
ESAs and Outcomes in CKD Patients Philip Lui PharmD The 13th Annual Contemporary Therapeutic Issues in Cardiovascular Disease May 8, 2010.
Vigneshwar Kasirajan, M.D. Division of Cardiothoracic Surgery Vigneshwar Kasirajan, M.D. Division of Cardiothoracic Surgery.
Early Goal Therapy in Severe Sepsis & Septic Shock
Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.
THE TRISS TRIAL Holst, L et al. Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock. New England Journal of Medicine October 9, 2014.
Transfusion Trends In Surgical Patients
Recombinant Factor VIIa as Adjunctive Therapy for Bleeding Control in Severely Injured Trauma Patients: Two Parallel Randomized, Placebo-Controlled, Double-
Is that Hemoglobin High Enough? COPYRIGHT © 2014, ALL RIGHTS RESERVED From the Publishers of.
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
The Effect of blood Storage Time Before & After Transfusion Ahmad Sh. Silmi Staff Specialist in Hemayology.
Risks and Indications for RBCs Transfusions David Stroncek, MD Chief, Laboratory Services Section Department of Transfusion Medicine, Clinical Center,
Red cells and the critically ill patient “Conservatives” or “Liberals” Dr A. Surekha Devi Consultant, Transfusion Medicine Hyderabad.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
What Is the Difference Between Blood and Chicken Soup?
Patterns of red blood cell transfusion use and outcomes in patients undergoing percutaneous coronary intervention in contemporary clinical practice: Insights.
The Patient Undergoing Surgery: Proven Steps to Better Outcomes Ariel U. Spencer, MD Lafayette Surgical Clinic Lafayette, Indiana.
Monitoring Fluid Responsiveness Murat Sungur, MD Erciyes University Medical School Department of Medicine Division of Critical Care Medicine.
BLOOD TRANSFUSIONS Dr. Tamara Wagenheim.
Reduction of RBC transfusions based on standardized hemoglobin evaluation for adult non-ICU patients Kathryn Curcione RN, BSN, ONC, NE-BC, Molly Rankin,
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Pediatric Septic Shock
Monthly Journal article review: Vimmi Kang PGY 2
Transfusion Strategies for Patients in Pediatric Intensive Care Units Lacroix J et al. NEJM 2007;356: Maggie Constantine, MD, FRCPC Resident, Transfusion.
Evaluation of CardioPAT R autotransfusion system in elective cardiac surgery. De Decker K. 1 ; Bogaert T 2* ; Gooris T 2* ; Stockman B 2 ; 1: Dept of Anesthesiology.
RALES: Randomized Aldactone Evaluation Study Purpose To determine whether the aldosterone antagonist spironolactone reduces mortality in patients with.
Advances in Transfusion and Blood Conservation Arman Kilic, MD Division of Cardiac Surgery, Department of Surgery, Johns Hopkins Hospital, Baltimore, MD.
Acute Kidney Injury after Cardiopulmonary Bypass Catherine Krawczeski, MD Associate Professor of Pediatrics University of Cincinnati College of Medicine.
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
G. Rainey Williams Symposium September 30, 2005 CABG in the Elderly Patient: On or Off pump? A Single Center Experience R. Nathan Grantham, M.D.
AIRE: Acute Infarction Ramipril Efficacy study Purpose To determine whether the ACE inhibitor ramipril reduces mortality in patients with evidence of heart.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
RBC transfusions in critically ill patients TMR Journal Club March 1, 2007 Maggie Constantine.
Age of Transfused Blood: Short-Term Mortality and Long-Term Survival after Cardiac Surgery Mark Stafford-Smith, MD, CM, FRCPC, FASE Professor of Anesthesiology.
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators N Engl J Med 2004: 350:
HOPE: Heart Outcomes Prevention Evaluation study Purpose To evaluate whether the long-acting ACE inhibitor ramipril and/or vitamin E reduce the incidence.
Top Papers in Critical Care 2013 Janna Landsperger RN, MSN, ACNP-BC.
Impact of a PRUDENT © Red Blood Cell Transfusion Strategy in Pediatric HSCT and Oncology Patients Results from the CHB Experience © 2009 All rights.
An Evidence-Based Approach to Transfusion of the Preterm Infant
Haemofiltration for sepsis: burial or resurrection?
Intravenous Erythropoietin in Patients with ST-Segment Elevation MI -- Study performed by: Najjar et al -- Presented by: Jay Hall PA-SII, Ali Rahimi MD.
LSU Journal Club Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia A Systematic Review and Meta-analysis Scott Hebert,
Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult ICU patients Crit Care Med 2007 ; 35 :
Anemia in CKD The TREAT Trial Reference Pfeiffer MA. A trial of Darbepoetin alpha in type II diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.
Update in Critical Care Medicine Ann Intern Med 2007;147:
Geriatrics Journal Club Yee Chuan Ang, MD Geriatric Medicine Fellow PGY-4 Boston University School of Medicine.
Transfusion thresholds for cancer patients
Surgical ICU, Heart Institute University of São Paulo
Blood transfusion: When to transfuse and risks involved
SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.
AUDIT OF RED BLOOD CELL TRANSFUSION PRACTICE IN THE ITU SETTING
Consultant CPD, November 23rd 2016
Blood Transfusion Evidence-Based Blood Therapeutics “7 is the NEW 10”
PRBC Transfusions Medicine Floors Internal Medicine, PGY-3
Monthly Journal article review: Vimmi Kang PGY 2
PPI prophylaxis for GI bleeding in ICU
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Red Cell Transfusion in Critical Care Patients Alan Tinmouth, MD MSc University of Ottawa Centre for Transfusion Research, Ottawa Health Research Institute and the Ottawa Hospital November 2009

Objectives Review the seminal observational and randomized clinical trials evaluating red cell transfusions in the critically ill. Understand the limitations of the current evidence surrounding red cell transfusions. Understand the limits and benefits of alternatives / strategies to reduce the need for red cell transfusions.

Case 1 Hebert, Crit Care Med 2005; 33; 7.

Anemia in the critically ill is very common 95% anemic by 3 rd day in ICU 40 – 45% of patients will receive RBCs Average = 5 units RBC Vincent et al, JAMA 2002; Corwin et al, CCM 2004

RBC Transfusions in Critical Care and Cardiac Surgery in Canada, Hutton et al. CJA 2005

Purpose of an RBC transfusion Increase O 2 delivery and consumption. Increase hemoglobin levels. Decrease morbidity and mortality.

The Role of Hemoglobin in O 2 Delivery (1) DO 2 = CO x (%sat x 1.39 x Hb) (2) CO = HR x stroke volume DO 2 = O 2 Delivery (ml/L) CO = Cardiac output(L/min) %Sat= % saturation of Hb Hb = Hemoglobin (g/L) 1.39 = O 2 carried in blood (ml/L)

Oxygen Delivery and RBC Transfusion VO 2 Delivery IndependentDelivery Dependent Critical DO 2 DO 2 At least 19 clinical studies evaluating impact RBCs on oxygen kinetics in humans Uniform increase in DO2 but not VO2 Hebert et al, CMAJ, 1997

Oxygen Delivery and Consumption following RBC transfusion Suttner et al. Anesth Analg 2004; 99: 2-11

Transfusion Requirements in Critical Care (TRICC) Hebert PC, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340(6): Purpose: To determine if a restrictive and liberal red cell transfusion strategy are equivalent in terms of effects on mortality and morbidity in volume resuscitated critically ill patients Hebert et al. NEJM 321: , 1999

Study design: Multicentre RCT Setting: 25 ICUs across Canada Study Population: Included Hb 3 unit transfusion in 12 hrs) Intervention: 7.0 g/dl vs 10.0 g/dl hemoglobin trigger Outcomes: 30 day all-cause mortality and organ failure TRICC Study Hebert et al. NEJM 321: , 1999

Hemoglobins over time Liberal strategy Restrictive strategy p<0.01 Hebert et al. NEJM 321: , 1999

Survival of all patients over 30 days Hebert et al. NEJM 321: , % 23.3%

Survival of patients < 55 years of age Hebert et al. NEJM 321: , 1999

TRICC – Mortality and MODS OutcomesLiberal RestrictiveP-Value (n=420)(n=418) Mortality No.(%) 30-day 98 (23.3)78 (18.7) day111(26.5)95(22.8)0.23 ICU 68 (16)56 (13)0.29 Hospital118(28.1)93(22.3)0.05 Organ Dysfunction MODS8.8 ± ± MODS* 11.8 ± ± Change in MODS1.26 ± ± Hebert et al. NEJM 321: , 1999

Case 1 Hebert, Crit Care Med 2005; 33; 7.

ICU Responses 1997 and 2003 Hebert, Crit Care Med 2005; 33; 7.

RBC transfusions and risk of death Marik and Corwin, CCM 2008;36:2667

Can we trust these studies? Inferences from these studies are weakened because: Logic of transfusions always being harmful?? Retrospective with limited data Minimal adjustment for confounding factors Timing of RBCs unknown Trigger unknown…admission hematocrit/nadir hematocrit Main culprit: “Confounding by Indication” –higher acuity → more aggressive care

Adverse Effects Associated with Transfusion Fever Neutrophilia Flushing Proinflammatory Capillary leak TRALI / ARDS MOF Other adverse effects of leukocytes Thrombosis Impaired O 2 delivery Acidosis K+, Na+, NH4+ Hypothermia Glucose Plasticisers Jaundice Thrombosis ? ARDS RES Blockade Microvascular Pathology Hypotension Flushing Anxiety GIT Symptoms Pain Proinflammatory PLASMA Cleavage / activation of Plasma proteins BUFFY COAT RED CELLS 1.Impaired RBC survival 2.Reduced efficacy 3.Adverse effects Chemical, Metabolic & Physical Haemolysis Billirubin LDH Iron Cytokines Kinins Complement Histimine Microaggregates Procoagulants

Consequences of Biochemical and BioMechanical Changes in Stored RBCs Left shift of oxygen- hemoglobin dissociation curve Loss of red blood cell deformability Increased RBC aggregation Increased RBC adhesion to endothelial cells Release of hypercoagulable microvessicles Increased NO scavenging Accumulation of cytokines Tinmouth. Transfusion 2006

Case 3 Hebert, Crit Care Med 2005; 33; 7.

TRICC and acuity of illness Hebert et al. NEJM 321: , 1999

Goal Directed Therapy in Early Sepsis Rivers et al. NEJM 2004; 345: 1368

Goal Directed Therapy in Early Sepsis Rivers et al. NEJM 2004; 345: 1368

Case 3

ICU Responses 1997 and 2003 Hebert, Crit Care Med 2005; 33; 7.

Case 2 Hebert, Crit Care Med 2005; 33; 7.

TRICC – Cardiovascular Disease Patients with Ischemic Heart Disease (n=257) Patients with cardiovascular diseases (n=357) Hebert et al. NEJM 321: , 1999

Complications during the ICU Stay ComplicationLiberal (n=420) Restrictive (n=418) P Values Cardiac No. (%)88 (21.0)55 (13.2)<0.01 Myocardial Infarction12 (2.9)3 (0.7)0.02 Pulmonary Edema45 (10.7)22 (5.3)<0.01 Angina9 (2.1)5 (1.2)0.28 Cardiac Arrest33 (7.9)29 (6.9)0.6 Pulmonary No. (%)122 (29.1)106 (25.4)0.22 ARDS48 (11.4)32 (7.7)0.06 Pneumonia86 (20.5)87 (20.8)0.92 Hebert et al. NEJM 321: , 1999

RBC transfusions in acute MI Wu. NEJM 2001; 345: 1230.

RBC transfusion in ACS Transfused patients were older, had more co- morbidities and higher mortality rates Rao. NEJM 2001; 345: 1230.

RBC transfusion in ACS Adjusted analysis showed higher mortality rate associated with transfusions –No associated with harm for nadir hct of ,25 –Increased mortality for nadir hct > 0.30 Rao. NEJM 2001; 345: 1230.

Case 2 Hebert, Crit Care Med 2005; 33; 7.

ICU Responses 1997 and 2003 Hebert, Crit Care Med 2005; 33; 7.

Case 4 Walsh, Transf 2009; epub.

TRICC and mechanical ventilation Hebert et al. NEJM 321: , 1999

Case 4 Walsh, Transf 2009; epub.

Case 5 28 year old Jehova Witness. Peripartum hemorrage taken to OR and hysterectomy performed. Bleeding now controlled. Admitted to ICU post-op with Hgb 28 g/L. Treatment recommendations ?

Alternatives to Red Cell Transfusions Erythropoietin Iron replacement Folate Other –Factor VIIa for bleeding –Reduce phlebotomy – pediatric tubes

EPO in Critical Care – Part 1 Corwin, JAMA 2002; 288: 2827.

EPO in Critical Care – Part 1 EPO raised hemoglobin (13.2 g/L vs. 9.4 g/L) EPO resulted in 19% reduction in number of units RBCs transfused

EPO in Critical Care – part II EPO raised increased hemoglobin (16 g/L vs. 12 g/L, p < 0.001) and resulted in higher hemoglobin levels. No difference in transfusion rates with restrictive transfusion policy Corwin, NEJM 2007; 357: 965.

EPO in Critical Care – part II Thrombosis Mortality Corwin, NEJM 2007; 357: 965.

Conclusions In critical care patients, restrictive RBC transfusion strategy is not worse than liberal transfusion strategy –Patients not likely to benefit from RBC transfusion are only likely to be harmed Results of TRICC not generalizable to all critically ill patients –e.g. cardiac and bleeding patient Alternatives to transfusions also have adverse effects –“best transfusion is not simply transfusion not given”